Cargando…

The Impact of Clopidogrel Resistance on Clinical Outcome of Iranian Patients Undergoing Percutaneous Coronary Intervention

The aim of current study was evaluating the frequency of clopidogrel resistance and its impact on clinical outcome of patients in Iranian patients. Patients undergoing percutaneous coronary intervention in Imam Hussein Medical center, Tehran, Iran, who received standard dosage of clopidogrel (Plavix...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haji Aghajani, Mohammad, Kobarfard, Farzad, Shojaei, Seyed pouzhia, Ahmadpour, Froozan, Safi, Olia, Kazemina, Neda, Zarepishe, Naeime, Sistanizad, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094421/ https://www.ncbi.nlm.nih.gov/pubmed/30127832

Ejemplares similares

Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention
por: Haji Aghajani, Mohammad, et al.
Publicado: (2013)

Potential Drug-drug Interactions in Post-CCU of a Teaching Hospital
por: Haji Aghajani, Mohammad, et al.
Publicado: (2013)

Association of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention
por: Namazi, Soha, et al.
Publicado: (2020)

Development of a scoring system for the prediction of in-hospital mortality among COVID-19 patients
por: Haji Aghajani, Mohammad, et al.
Publicado: (2021)

Errors Related to Medication Reconciliation: A Prospective Study in Patients Admitted to the Post CCU
por: Haji Aghajani, Mohammad, et al.
Publicado: (2016)

Impact of a High-protein Nutritional Intake on the Clinical Outcome of the Neurocritical Patients
por: Ahmadpour, Forouzan, et al.
Publicado: (2020)

Evaluation of pharmacokinetic and pharmacodynamic parameters of meropenem in critically ill patients with acute kidney disease
por: Hassanpour, Rezvan, et al.
Publicado: (2021)

Effect of Underlying Cardiovascular Disease on the Prognosis of COVID-19 Patients; a Sex and Age-Dependent Analysis
por: Haji Aghajani, Mohammad, et al.
Publicado: (2021)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
por: YANG, Bin, et al.
Publicado: (2018)

Intuitive Decision-making by Iranian Nurses of Patients with COVID-19: A Qualitative Study
por: Aghajani, Mohammad, et al.
Publicado: (2021)

Percutaneous Mitral Valve Repair with the Edge-to-Edge Technique: Case Series of First Iranian Experience
por: Kassaian, Seyed Ebrahim, et al.
Publicado: (2014)

Comment on “The Effect of Nitroglycerine Infusion on Postoperative Pain in Lower Limb Surgery: A Clinical Double-Blind Study”
por: Sistanizad, Mohammad, et al.
Publicado: (2019)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Norgard, Nicholas B, et al.
Publicado: (2009)

Prognostic implications of calculated Apo‐lipoprotein B in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcome is tied to lower cut‐points
por: Ghodsi, Saeed, et al.
Publicado: (2021)

Comparing the Characteristics of Mucormycosis Between Cases with and without COVID-19; a Cross-sectional Study
por: Sistanizad, Mohammad, et al.
Publicado: (2022)

Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention
por: Jeong, Young-Hoon, et al.
Publicado: (2012)

Electrocardiographic Findings and In-Hospital Mortality of COVID-19 Patients; a Retrospective Cohort Study
por: Haji Aghajani, Mohammad, et al.
Publicado: (2021)

Risk Factors of Readmission in COVID-19 Patients; a Retrospective 6-Month Cohort Study
por: Haji Aghajani, Mohammad, et al.
Publicado: (2022)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019)

Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Zhang, Xiaoyan, et al.
Publicado: (2019)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention
por: Chen, Lida, et al.
Publicado: (2022)

One-Year Outcome of Patients with Coronary Artery Ectasia Undergoing Percutaneous Coronary Intervention: Clinical Implications and Question Marks
por: Amirzadegan, Alireza, et al.
Publicado: (2020)

Is a Low Incidence Rate of Ventilation Associated Pneumonia Associated with Lower Mortality? a Descriptive Longitudinal Study in Iran
por: Chouhdari, Arezoo, et al.
Publicado: (2018)

Is cardiac Troponin I Considered as A Predictor of In-hospital Mortality among COVID-19 Patients? A Retrospective Cohort Study
por: Haji Aghajani, Mohammad, et al.
Publicado: (2022)

Partial Fractionation of Venoms from Two Iranian Vipers, Echis carinatus and Cerastes persicus Fieldi and Evaluation of Their Antiplatelet Activity
por: Mehdizadeh Kashani, Toktam, et al.
Publicado: (2012)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Correction: Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
Publicado: (2019)

Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Jianan, et al.
Publicado: (2021)

High-Maintenance-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
por: Chen, Yu, et al.
Publicado: (2013)

Changes of High Sensitivity C-Reactive Protein During Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2015)

Comparative study of ticagrelor and clopidogrel in therapeutic effect of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Yao, Guangtao, et al.
Publicado: (2017)

Clopidogrel non-responsiveness in patients undergoing percutaneous coronary intervention using the VerifyNow test: frequency and predictors
por: Yaseen, Israa Fadhil, et al.
Publicado: (2019)

Short-term Safety and Mid-term Efficacy of Prasugrel Versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention
por: Koyabu, Yota, et al.
Publicado: (2019)

Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
por: Habibi, Zarina, et al.
Publicado: (2023)

Did Iranians respect health measures during Nowruz holidays? A study on Iranians’ knowledge, attitude and practice toward COVID-19
por: NAKHOSTIN-ANSARI, AMIN, et al.
Publicado: (2021)

Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
por: Sistanizad, Mohammad, et al.
Publicado: (2011)

Effect of Ticagrelor Compared to Clopidogrel on Short-term Outcomes of COVID-19 Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention; a Randomized Clinical Trial
por: Arefizadeh, Reza, et al.
Publicado: (2023)

Depression and Anxiety among Iranian Medical Students during COVID-19 Pandemic
por: Nakhostin-Ansari, Amin, et al.
Publicado: (2020)

Evaluation of Glutathione S-transferase T1 (GSTT1) deletion polymorphism on type 2 diabetes mellitus risk in a sample of Yazdian females in Yazd, Iran
por: Khalilzadeh, Saeedhossein, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_27hiit7aeppn73gqgsap2q7r53